# ALGS (Aligos Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Aligos Therapeutics, Inc. reported $5.83M in revenue and a net loss of $66.28M for the trailing twelve months ended September 30, 2026 (up 281.9% year over year), with a -1244.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/ALGS
- Markdown: https://convexityos.com/fundamentals/ALGS.md
- SEC CIK: 0001799448
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001799448&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.83M | +281.9% YoY |
| Operating Income | TTM | -$72.52M | -1244.2% margin |
| Net Income | TTM | -$66.28M | -1137.2% net margin |
| Diluted EPS | TTM | -$6.34 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $31.09M | Total debt: $11.90M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.19M | $3.61M | $6.19M | $0 | $0 | $0 | -- |
| Research & Development | $69.45M | $70.27M | $73.04M | $85.08M | $104.2M | $79.89M | $44.04M |
| Total Operating Expenses | $90.17M | $93.10M | $103.7M | $111.5M | $132.7M | $97.83M | $54.04M |
| **Operating Income** | -$87.98M | -$89.15M | -$88.13M | -$97.58M | -$128.3M | -$97.83M | -$54.04M |
| **EBITDA** | -$87.06M | -$88.13M | -$86.57M | -$95.27M | -$125.3M | -$95.10M | -$52.65M |
| Income Before Tax | -$23.88M | -$130.9M | -$86.88M | -$95.94M | -$128.2M | -$108.4M | -$52.18M |
| Income Tax Expense | $314K | $331K | $795K | $106K | $143K | $161K | $85K |
| **Net Income** | -$24.19M | -$131.2M | -$87.68M | -$96.05M | -$128.3M | -$108.5M | -$52.26M |
| Basic EPS | -$2.45 | -$20.94 | -$34.20 | -$56.25 | -$80.50 | -$271.75 | -$651.00 |
| **Diluted EPS** | -$2.45 | -$20.94 | -$34.20 | -$56.25 | -$80.50 | -$271.75 | -$651.00 |
| Basic Shares Outstanding | 9.9M | 6.3M | 2.6M | 1.7M | 1.6M | 399.5K | 80.3K |
| Diluted Shares Outstanding | 9.9M | 6.3M | 2.6M | 1.7M | 1.6M | 399.5K | 80.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.83M | $0 | $2.83M | $169K | $741K | $965K | $311K | $606K |
| Research & Development | $18.89M | $24.05M | $23.35M | $17.04M | $23.94M | $13.98M | $14.50M | $16.03M |
| Total Operating Expenses | $24.76M | $29.67M | $29.76M | $21.98M | $29.10M | $19.53M | $19.55M | $21.19M |
| **Operating Income** | -$21.89M | -$1.89M | -$26.93M | -$21.81M | -$28.36M | -$18.57M | -$19.24M | -$20.56M |
| **EBITDA** | -$21.59M | -$1.59M | -$26.58M | -$21.56M | -$28.16M | -$18.27M | -$19.05M | -$20.32M |
| Income Before Tax | -$21.53M | $1.31M | -$22.72M | -$19.85M | -$31.48M | -$15.68M | $43.13M | -$82.12M |
| Income Tax Expense | $326K | $2.81M | $317K | $30K | $56K | $185K | $43K | $27K |
| **Net Income** | -$21.86M | -$1.50M | -$23.04M | -$19.88M | -$31.54M | -$15.86M | $43.09M | -$82.15M |
| Basic EPS | -$2.09 | -$0.14 | -$2.21 | -- | -$3.04 | -$1.53 | $5.12 | -- |
| **Diluted EPS** | -$2.09 | -$0.14 | -$2.21 | -- | -$3.04 | -$1.53 | -$2.11 | -- |
| Basic Shares Outstanding | 10.5M | 10.4M | 10.4M | -- | 10.4M | 10.4M | 8.4M | -- |
| Diluted Shares Outstanding | 10.5M | 10.4M | 10.4M | -- | 10.4M | 10.4M | 8.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $18.30M | $37.00M | $135.7M | $81.35M | $186.8M | $220.4M | $69.56M |
| Short-Term Investments | $59.54M | $19.94M | -- | $44.48M | $3.92M | $23.13M | $48.10M |
| **Cash & Short-Term Investments** | $77.80M | $56.90M | $135.7M | $125.8M | $205.8M | $243.5M | $117.7M |
| Other Current Assets | $4.91M | $5.09M | $5.31M | $7.60M | $13.53M | $5.94M | $2.02M |
| **Total Current Assets** | $82.86M | $62.14M | $141.1M | $133.5M | $204.4M | $250.0M | $120.2M |
| Property, Plant & Equipment, Net | $1.87M | $2.36M | $3.26M | $4.82M | $6.18M | $8.01M | $8.52M |
| Long-Term Investments | -- | -- | -- | -- | $15.11M | -- | $10.02M |
| Other Non-Current Assets | $715K | $627K | $625K | $634K | $866K | $377K | $188K |
| **Total Non-Current Assets** | $5.67M | $7.95M | $10.44M | $13.15M | $30.95M | $15.29M | $26.29M |
| **Total Assets** | $88.53M | $70.09M | $151.5M | $146.7M | $235.4M | $265.3M | $146.5M |
| Accounts Payable | $3.98M | $2.57M | $2.52M | $4.74M | $3.02M | $3.31M | $3.77M |
| Deferred Revenue (Current) | $0 | $151K | $1.31M | -- | -- | $7.89M | -- |
| **Total Current Liabilities** | $21.23M | $21.74M | $23.91M | $33.13M | $38.96M | $30.27M | $13.82M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $4.11M | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | $133K | $379K | -- |
| **Total Non-Current Liabilities** | $13.76M | $77.33M | $35.54M | $9.66M | $11.68M | $14.99M | $15.51M |
| **Total Liabilities** | $34.99M | $99.07M | $59.45M | $42.79M | $50.64M | $45.26M | $29.33M |
| **Total Debt (incl. Leases)** | $5.25M | $8.38M | $11.14M | $12.57M | $14.46M | $13.01M | $14.33M |
| Common Stock | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | $0 |
| Retained Earnings | -$642.2M | -$618.0M | -$486.8M | -$399.1M | -$303.1M | -$174.7M | -$66.20M |
| Accumulated Other Comp. Income | $468K | $451K | $545K | $401K | $452K | -$188K | -$115K |
| **Total Stockholders' Equity** | $53.55M | -$28.97M | $92.08M | $103.9M | $184.7M | $220.0M | -$64.89M |
| Total Equity | $53.55M | -$28.97M | $92.08M | $103.9M | $184.7M | $220.0M | -$64.89M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $31.09M | $30.38M | $29.98M | $18.30M | $41.95M | $18.66M | $73.76M | $37.00M |
| Short-Term Investments | $0 | $0 | $24.93M | $59.54M | $57.15M | $104.3M | $64.10M | $19.94M |
| **Cash & Short-Term Investments** | $31.09M | $30.38M | $54.90M | $77.80M | $99.10M | $122.9M | $137.9M | $56.90M |
| Accounts Receivable, Net | -- | $27.78M | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $2.94M | $3.93M | $4.55M | $4.91M | $4.23M | $4.89M | $5.23M | $5.09M |
| **Total Current Assets** | $34.68M | $62.13M | $59.63M | $82.86M | $103.4M | $127.9M | $143.2M | $62.14M |
| Property, Plant & Equipment, Net | $1.21M | $1.33M | $1.59M | $1.87M | $2.04M | $2.06M | $2.21M | $2.36M |
| Other Non-Current Assets | $268K | $759K | $759K | $715K | $713K | $640K | $632K | $627K |
| **Total Non-Current Assets** | $12.51M | $4.20M | $4.93M | $5.67M | $6.33M | $6.76M | $7.49M | $7.95M |
| **Total Assets** | $47.19M | $66.33M | $64.56M | $88.53M | $109.8M | $134.7M | $150.7M | $70.09M |
| Accounts Payable | $3.21M | $6.43M | $7.64M | $3.98M | $4.65M | $3.94M | $4.46M | $2.57M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $168K | $579K | -- | $151K |
| **Total Current Liabilities** | $19.60M | $28.34M | $23.32M | $21.23M | $21.99M | $20.27M | $18.95M | $21.74M |
| **Total Non-Current Liabilities** | $16.28M | $6.10M | $9.45M | $13.76M | $15.94M | $12.57M | $15.31M | $77.33M |
| **Total Liabilities** | $35.88M | $34.44M | $32.77M | $34.99M | $37.93M | $32.84M | $34.25M | $99.07M |
| **Total Debt (incl. Leases)** | $11.90M | $3.50M | $4.35M | $5.25M | $6.07M | $6.88M | $7.87M | $8.38M |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K |
| Retained Earnings | -$688.6M | -$666.7M | -$665.2M | -$642.2M | -$622.3M | -$590.8M | -$574.9M | -$618.0M |
| Accumulated Other Comp. Income | $437K | $437K | $438K | $468K | $455K | $420K | $447K | $451K |
| **Total Stockholders' Equity** | $11.31M | $31.88M | $31.79M | $53.55M | $71.83M | $101.9M | $116.4M | -$28.97M |
| Total Equity | $11.31M | $31.88M | $31.79M | $53.55M | $71.83M | $101.9M | $116.4M | -$28.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.19M | -$131.2M | -$87.68M | -$96.05M | -$128.3M | -$108.5M | -$52.26M |
| Depreciation & Amortization | $930K | $1.03M | $1.56M | $2.31M | $3.02M | $2.73M | $1.40M |
| Stock-Based Compensation | $5.04M | $8.45M | $12.65M | $14.69M | $13.46M | $2.98M | $752K |
| Change in Payables | $1.41M | $54K | -$2.22M | $1.72M | -$313K | -$130K | $385K |
| **Operating Cash Flow** | -$82.50M | -$80.74M | -$79.00M | -$79.39M | -$115.7M | -$74.26M | -$46.77M |
| Capital Expenditure | -- | -$130K | -$19K | -$943K | -$892K | -$2.06M | -$2.79M |
| **Free Cash Flow** | -- | -$80.87M | -$79.02M | -$80.33M | -$116.6M | -$76.33M | -$49.55M |
| **Investing Cash Flow** | -$37.83M | -$18.28M | $44.98M | -$26.29M | $3.02M | $32.76M | $6.79M |
| Common Stock Issued | -- | -- | $23K | -- | -- | -- | -- |
| **Financing Cash Flow** | $101.6M | $355K | $88.33M | $164K | $78.68M | $192.3M | $85.53M |
| **Net Change in Cash** | -$18.69M | -$98.67M | $54.31M | -$105.5M | -$33.96M | $150.8M | $45.56M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.86M | -$1.50M | -$23.04M | -$19.88M | -$31.54M | -$15.86M | $43.09M | -$82.15M |
| Depreciation & Amortization | $300K | $300K | $346K | $257K | $200K | $300K | $194K | $241K |
| Stock-Based Compensation | $1.28M | $1.36M | $1.31M | $1.46M | $1.47M | $1.16M | $959K | $1.71M |
| Change in Payables | -$3.22M | -$1.21M | $3.66M | -$669K | $752K | -$402K | $1.73M | -$169K |
| **Operating Cash Flow** | $1.45M | -$24.95M | -$23.13M | -$21.75M | -$24.34M | -$15.50M | -$20.91M | -$18.40M |
| **Investing Cash Flow** | -$127K | $25.00M | $34.93M | -$2.02M | $47.68M | -$39.42M | -$44.07M | $19.97M |
| **Financing Cash Flow** | -$8.0K | $220K | -$62K | $123K | -$53K | -$177K | $101.7M | $97K |
| **Net Change in Cash** | $1.32M | $269K | $11.74M | -$23.64M | $23.29M | -$55.10M | $36.77M | $1.67M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -4024.9% | -2469.0% | -1423.5% | -- | -- | -- | -- |
| **Net Profit Margin** | -1106.7% | -3633.6% | -1416.2% | -- | -- | -- | -- |
| Return on Equity (ROE) | -45.2% | -- | -95.2% | -92.4% | -69.5% | -49.3% | -- |
| Return on Assets (ROA) | -27.3% | -187.2% | -57.9% | -65.5% | -54.5% | -40.9% | -35.7% |
| Current Ratio | 3.90x | 2.86x | 5.90x | 4.03x | 5.25x | 8.26x | 8.70x |
| Quick Ratio | 3.66x | 2.62x | 5.68x | 3.80x | 5.28x | 8.04x | 8.52x |
| Debt to Equity | 0.10x | -- | 0.12x | 0.12x | 0.08x | 0.06x | -- |
| **Revenue Growth (YoY)** | -39.5% | -41.7% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1244.2% | -2112.1% | -2033.4% | -4024.9% | -3306.7% | -2506.5% | -2675.1% | -2469.0% |
| **Net Profit Margin** | -1137.2% | -2031.1% | -1919.7% | -1106.7% | -3296.3% | -2368.6% | -1649.9% | -3633.6% |
| Return on Equity (ROE) | -586.3% | -238.2% | -284.1% | -45.2% | -120.4% | -72.8% | -45.7% | -- |
| Return on Assets (ROA) | -140.5% | -114.5% | -139.9% | -27.3% | -78.8% | -55.1% | -35.3% | -187.2% |
| Current Ratio | 1.77x | 2.19x | 2.56x | 3.90x | 4.70x | 6.31x | 7.56x | 2.86x |
| Quick Ratio | 1.59x | 2.05x | 2.35x | 3.66x | 4.51x | 6.06x | 7.28x | 2.62x |
| Debt to Equity | 1.05x | 0.11x | 0.14x | 0.10x | 0.08x | 0.07x | 0.07x | -- |
| **Revenue Growth (YoY)** | +281.9% | -100.0% | +810.0% | -72.1% | -40.7% | -9.0% | -55.2% | -9.8% |
| **Net Income Growth (YoY)** | -- | -- | -153.5% | -- | -- | -413.4% | -- | -- |
| EPS Growth (YoY) | -- | -- | -143.2% | -- | -- | -288.9% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
